X-84361584-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS2
The NM_001177479.2(HDX):c.1334G>A(p.Arg445Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000183 in 1,199,301 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 10 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001177479.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HDX | NM_001177479.2 | c.1334G>A | p.Arg445Gln | missense_variant | 6/11 | ENST00000373177.3 | NP_001170950.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HDX | ENST00000373177.3 | c.1334G>A | p.Arg445Gln | missense_variant | 6/11 | 1 | NM_001177479.2 | ENSP00000362272 | P1 | |
HDX | ENST00000297977.9 | c.1334G>A | p.Arg445Gln | missense_variant | 5/10 | 1 | ENSP00000297977 | P1 | ||
HDX | ENST00000506585.6 | c.1160G>A | p.Arg387Gln | missense_variant | 5/10 | 2 | ENSP00000423670 |
Frequencies
GnomAD3 genomes AF: 0.0000269 AC: 3AN: 111698Hom.: 0 Cov.: 23 AF XY: 0.0000295 AC XY: 1AN XY: 33888
GnomAD3 exomes AF: 0.00000577 AC: 1AN: 173289Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 58529
GnomAD4 exome AF: 0.0000175 AC: 19AN: 1087603Hom.: 0 Cov.: 26 AF XY: 0.0000254 AC XY: 9AN XY: 353917
GnomAD4 genome AF: 0.0000269 AC: 3AN: 111698Hom.: 0 Cov.: 23 AF XY: 0.0000295 AC XY: 1AN XY: 33888
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 27, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at